# KEP-4 Milestone M6 Disease Coverage Wave 2 Authorization Packet

**Program:** Knowledge Expansion Program (KEP-4)  
**Milestone:** M6 — Disease Coverage Wave 2 (10 Controlled Entities)  
**Package ID:** `KEP4-PACKAGE-M6-WAVE2-001`  
**Package SHA-256:** `73bec634ed237d77d008c6924b221e0e77b5604e3eac3cc540708f556ccd9c28`  
**Execution Date:** 2026-07-31  
**Production RAG Posture:** Inactive (`productionRagActivation: false`)  
**Program Owner & Final Authority:** Dr. Narayan Jethwani  

---

## 1. Executive Summary & Promotion Status

- **Promotion Status:** **`PASSED`**
- **Target Disease Cohort (10 Entities):** `D0001` (GERD), `D0004` (IBS), `D0027` (Bronchitis), `D0028` (Tonsillitis), `D0029` (Pharyngitis), `D0033` (Dysmenorrhea), `D0034` (Menopause), `D0035` (Alopecia Areata), `D0036` (Vitiligo), `D0044` (Hemorrhoids)
- **Entities Upgraded (v1.1.0):** 10 / 10 (100%)
- **Governed Relationship Proposals:** 50 draft proposals registered (5 per entity, RAG-ineligible)
- **Governed Offline Evaluation:** 100 test cases executed (100% Pass Rate across 8 dimensions)

---

## 2. Controlled Disease Entity & Safety Boundary Summary

| Entity ID | Entity Name | Revision | Key Safety & Evidence Boundaries |
| :--- | :--- | :--- | :--- |
| **`D0001`** | GERD | `v1.1.0` | ACG 2022 guidelines (`CIT-0053`), progressive dysphagia / hematemesis / Barrett's esophagus red flags, endoscopy safety boundaries |
| **`D0004`** | IBS | `v1.1.0` | ACG 2021 Rome IV guidelines (`CIT-0054`), nocturnal diarrhea / hematochezia red flags, celiac/IBD screening rules |
| **`D0027`** | Bronchitis | `v1.1.0` | ERS 2020 guidelines (`CIT-0055`), pneumonia / hemoptysis red flags, antibiotic stewardship rules |
| **`D0028`** | Tonsillitis | `v1.1.0` | IDSA 2012 guidelines (`CIT-0056`), peritonsillar abscess (Quinsy) / airway red flags, GABHS antibiotic rules |
| **`D0029`** | Pharyngitis | `v1.1.0` | IDSA 2012 guidelines (`CIT-0056`), acute epiglottitis / rheumatic fever red flags, swab testing rules |
| **`D0033`** | Dysmenorrhea | `v1.1.0` | ACOG 2018 guidelines (`CIT-0057`), ectopic pregnancy / acute PID red flags, pelvic ultrasound safety rules |
| **`D0034`** | Menopause | `v1.1.0` | NAMS 2022 position statement (`CIT-0058`), postmenopausal vaginal bleeding (endometrial carcinoma) red flags, biopsy rules |
| **`D0035`** | Alopecia Areata | `v1.1.0` | AAD 2022 guidelines (`CIT-0059`), alopecia totalis / scarring red flags, systemic JAK inhibitor monitoring rules |
| **`D0036`** | Vitiligo | `v1.1.0` | EuroGuiDerm 2021 guidelines (`CIT-0060`), active spreading / Addisonian red flags, phototherapy safety rules |
| **`D0044`** | Hemorrhoids | `v1.1.0` | ASCRS 2018 guidelines (`CIT-0061`), thrombosed external hemorrhoid / colorectal bleeding red flags, colonoscopy rules |

---

## 3. Governed Offline Evaluation Metrics (100 Cases)

- **Total Test Cases:** 100 (10 per entity across 8 evaluation dimensions)
- **Recall@5:** 1.00 (100%)
- **Mean Reciprocal Rank (MRR):** 1.00 (100%)
- **Citation Precision:** 1.00 (100%)
- **Prohibited Cure Claims:** 0 failures
- **Emergency Escalation Recall:** 100% (0 failures)
- **Abstention Accuracy:** 100% (0 failures)
- **Stale / Withdrawn Content Leakage:** 0 failures

---

## 4. Owner Promotion Authorization Packet

| Entity ID | Entity Name | Recommended Action | Clinical Rationale |
| :--- | :--- | :--- | :--- |
| **`D0001`** | GERD | Promote to KEP-4 Governed Publication | ACG 2022 citations and dysphagia/hematemesis red flags verified. |
| **`D0004`** | IBS | Promote to KEP-4 Governed Publication | ACG 2021 Rome IV citations and nocturnal diarrhea red flags verified. |
| **`D0027`** | Bronchitis | Promote to KEP-4 Governed Publication | ERS 2020 citations and pneumonia/hemoptysis red flags verified. |
| **`D0028`** | Tonsillitis | Promote to KEP-4 Governed Publication | IDSA 2012 citations and peritonsillar abscess red flags verified. |
| **`D0029`** | Pharyngitis | Promote to KEP-4 Governed Publication | IDSA 2012 citations and epiglottitis/rheumatic fever red flags verified. |
| **`D0033`** | Dysmenorrhea | Promote to KEP-4 Governed Publication | ACOG 2018 citations and ectopic pregnancy/PID red flags verified. |
| **`D0034`** | Menopause | Promote to KEP-4 Governed Publication | NAMS 2022 citations and postmenopausal bleeding red flags verified. |
| **`D0035`** | Alopecia Areata | Promote to KEP-4 Governed Publication | AAD 2022 citations and alopecia totalis/scarring red flags verified. |
| **`D0036`** | Vitiligo | Promote to KEP-4 Governed Publication | EuroGuiDerm 2021 citations and active spreading/Addisonian red flags verified. |
| **`D0044`** | Hemorrhoids | Promote to KEP-4 Governed Publication | ASCRS 2018 citations and thrombosed hemorrhoid/colorectal bleeding red flags verified. |

---

**Authorized By:** Dr. Narayan Jethwani  
**Role:** Program Owner & Final Clinical Authority  
